Gerhard Ehninger
About
Gerhard Ehninger is a scholar working on Hematology, Oncology and Molecular Biology.
According to data from OpenAlex, Gerhard Ehninger has authored 678 papers receiving a total of 25.0k indexed citations (citations by other indexed papers that have themselves been cited), including 413 papers in Hematology, 190 papers in Oncology and 132 papers in Molecular Biology. Recurrent topics in Gerhard Ehninger's work include Acute Myeloid Leukemia Research (235 papers), Hematopoietic Stem Cell Transplantation (214 papers) and Chronic Myeloid Leukemia Treatments (86 papers). Gerhard Ehninger is often cited by papers focused on Acute Myeloid Leukemia Research (235 papers), Hematopoietic Stem Cell Transplantation (214 papers) and Chronic Myeloid Leukemia Treatments (86 papers). Gerhard Ehninger collaborates with scholars based in Germany, United States and France. Gerhard Ehninger's co-authors include Martin Bornhäuser, Christian Thiede, Markus Schaich, Thomas Illmer, Uwe Platzbecker, Brigitte Mohr, Andreas Neubauer, Ulrich S. Schuler, Christoph Röllig and Martin Wermke and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
In The Last Decade
Gerhard Ehninger
656 papers receiving 24.4k citations
Hit Papers
Peers
Gerhard Ehninger
Hillard M. Lazarus United States
Arnold Ganser Germany
Robert Peter Gale United States
Jack W. Singer United States
Jakob Passweg Switzerland
H. Joachim Deeg United States
Gèrard Socié France
Dietger Niederwieser Germany
Aloïs Gratwohl Switzerland
Franco Locatelli Italy
Citations per year, relative to Gerhard Ehninger Gerhard Ehninger (= 1×)
peers
Hillard M. Lazarus
Countries citing papers authored by Gerhard Ehninger
Since
Specialization
Citations
This map shows the geographic impact of Gerhard Ehninger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Ehninger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Ehninger more than expected).
Fields of papers citing papers by Gerhard Ehninger
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Gerhard Ehninger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Ehninger. The network helps show where Gerhard Ehninger may publish in the future.
Co-authorship network of co-authors of Gerhard Ehninger
This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Ehninger. A scholar is included among the top collaborators of Gerhard Ehninger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Ehninger. Gerhard Ehninger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Stasik, Sebastian, Jan‐Niklas Eckardt, Christoph Röllig, et al.. (2025). The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML . British Journal of Haematology. 206(5). 1373–1379.
2.
Sockel, Katja, Friedrich Stölzel, Christoph Röllig, et al.. (2022). Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse. SHILAP Revista de lepidopterología.
3.
Hölig, Kristina, Helmuth Schmidt, Gero Hütter, et al.. (2020). Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. Bone Marrow Transplantation. 56(3). 635–645.
4.
Baron, Frédéric, Myriam Labopin, Annalisa Ruggeri, et al.. (2019). Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT. Blood Cancer Journal. 9(4).
5.
Koristka, Stefanie, Alexandra Kegler, Ralf Bergmann, et al.. (2018). Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology. Journal of Autoimmunity. 90. 116–131.
6.
Heidrich, Katharina, Malte von Bonin, Friedrich Stölzel, et al.. (2018). Pilot Study on Mass Spectrometry–Based Analysis of the Proteome of CD34+CD123+ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia. Proteomes. 6(1). 11–11.
7.
Canaani, Jonathan, Bipin N. Savani, Myriam Labopin, et al.. (2017). Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT. Haematologica. 102(6). 1066–1074.
8.
Schuler, Markus K., Stephan Richter, Gerhard Ehninger, Martin Bornhäuser, & Leopold Hentschel. (2017). A cluster-randomised, controlled proof-of-concept study to explore the feasibility and effect of a patient-directed intervention on quality of life in patients with advanced soft tissue sarcoma. BMJ Open. 7(6). e014614–e014614.
9.
Bochtler, Tilmann, Friedrich Stölzel, Christoph E. Heilig, et al.. (2013). Clonal Heterogeneity As Detected by Metaphase Karyotyping Is an Indicator of Poor Prognosis in Acute Myeloid Leukemia. Journal of Clinical Oncology. 31(31). 3898–3905.
10.
Middeke, Jan Moritz, Dietrich W. Beelen, Michael Stadler, et al.. (2012). Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q−. Blood. 120(12). 2521–2528.
11.
Wermke, Martin, Anne Schmidt, Jan Moritz Middeke, et al.. (2012). MRI-Based Liver Iron Content Predicts for Nonrelapse Mortality in MDS and AML Patients Undergoing Allogeneic Stem Cell Transplantation. Clinical Cancer Research. 18(23). 6460–6468.
12.
Schmid, Christoph, Myriam Labopin, Arnon Nagler, et al.. (2007). Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party. Journal of Clinical Oncology. 25(31). 4938–4945.
13.
Freund, Daniel, Sabine Boxberger, Uwe Streller, et al.. (2006). Polarization of Human Hematopoietic Progenitors During Contact with Multipotent Mesenchymal Stromal Cells: Effects on Proliferation and Clonogenicity. Stem Cells and Development. 15(6). 815–829.
14.
Esteve, Jordi, Myriam Labopin, Jürgen Finke, et al.. (2004). Allogeneic Stem-Cell Transplantation for Patients with De Novo Acute Myeloid Leukemia Not in Complete Response: Results of a Survey from the European Group for Blood and Bone Marrow Transplantation (EBMT).. Blood. 104(11). 2302–2302.
15.
Babatz, Jana, Christoph Röllig, Uta Oelschlägel, et al.. (2003). Large-Scale Immunomagnetic Selection of CD14 + Monocytes to Generate Dendritic Cells for Cancer Immunotherapy: A Phase I Study. Journal of Hematotherapy & Stem Cell Research. 12(5). 515–523.
16.
Schaich, Markus, Ulrich Pascheberg, Brigitte Mohr, et al.. (2002). Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome.. PubMed. 87(5). 455–64.
17.
Miehlke, Stephan, Jun Yu, Matthias P. Ebert, et al.. (2002). Expression of G1 Phase Cyclins in Human Gastric Cancer and Gastric Mucosa of First-Degree Relatives. Digestive Diseases and Sciences. 47(6). 1248–1256.
18.
Bornhäuser, Martin, et al.. (1998). Fluorescence In Situ Hybridization for the BCR/ABL Rearrangement Is Dependent on the Percentage of Nonlymphocytic Cells in Peripheral Blood Stem Cell Harvests. Journal of Hematotherapy. 7(5). 425–430.
19.
Ho, Anthony D., T. Lipp, Gerhard Ehninger, et al.. (1988). Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen.. Journal of Clinical Oncology. 6(2). 213–217.
20.
Ehninger, Gerhard, H. Einsele, R. Dopfer, & H. D. Waller. (1987). The role of total body irradiation in conditioning adults for bone marrow transplantation. Strahlentherapie und Onkologie. 163(4). 210–211.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hillard M. Lazarus Breakdown of academic impact, for papers by Arnold Ganser Breakdown of academic impact, for papers by Robert Peter Gale Breakdown of academic impact, for papers by Jack W. Singer Breakdown of academic impact, for papers by Jakob Passweg Breakdown of academic impact, for papers by H. Joachim Deeg Breakdown of academic impact, for papers by Gèrard Socié Breakdown of academic impact, for papers by Dietger Niederwieser Breakdown of academic impact, for papers by Aloïs Gratwohl Breakdown of academic impact, for papers by Franco Locatelli